Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Application of Array CGH technique for the clinical diagnosis of developmental delay and congenital malformations in Saudi Arabia [244k]

ABSTRACT: Application of Array CGH technique for the clinical diagnosis of developmental delay and congenital malformations in Saudi Arabia [244k]

PROVIDER: PRJNA754156 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Application of Array CGH technique for the clinical diagnosis of developmental delay and congenital malformations in Saudi Arabia

Project description:Application of Array CGH technique for the clinical diagnosis of developmental delay and congenital malformations in Saudi Arabia

| PRJNA754451 | ENA

Application of Array CGH technique for the clinical diagnosis of developmental delay and congenital malformations in Saudi Arabia [400k]

Project description:Chromosomal imbalances are implicated in the etiology of developmental delay (DD) and congenital malformation (CM). We therefore conducted high resolution array comparative genomic hybridization (array CGH) of sixty three Saudi patients [11 by Agilent-001850/CGH1x244A and 52 by Agilent-014693/CGH2x400k] for investigating and understanding the genetic heterogeneity underlying DD/CM. A total of 76 disease associated copy number variants (CNVs) were detected in twenty four patients including 1p36, 1q21, 3p23, 6p24, 7q11, 8q24, 9q33, 10p14, 11p15, 11q12, 11q24, 13q21, 15q13, 16p13, 18q23, trisomy 18, 20q11, 21q22, 22q11.21, 47,XXY and 45,X0. The diagnosis rate of array CGH was 2.6 times higher than karyotyping.

2021-08-13 | GSE182081 | GEO

Application of Array CGH technique for the clinical diagnosis of developmental delay and congenital malformations in Saudi Arabia [244k]

2021-08-13 | GSE181995 | GEO

Application of Array CGH technique for the clinical diagnosis of developmental delay and congenital malformations in Saudi Arabia [400k]

Project description:Application of Array CGH technique for the clinical diagnosis of developmental delay and congenital malformations in Saudi Arabia [400k]

| PRJNA754450 | ENA

Application of Array CGH technique for the clinical diagnosis of developmental delay and congenital malformations in Saudi Arabia

Project description:This SuperSeries is composed of the SubSeries listed below.

2021-08-13 | GSE182101 | GEO

MDR UPEC in Saudi Arabia

Project description:Genomic characterization of Multi-Drug Resistant Uropathogenic Escherichia coli isolates from Riyadh, Saudi Arabia

| PRJEB17503 | ENA

Gene expression profiling and pathway analysis of human bronchial epithelial cells exposed to airborne particulate matter collected from Saudi Arabia

Project description:Whole transcript expression was profiled using the Affymetrix 1.0 array in human bronchial epithelial cells exposed to PM collected from Saudi Arabia for 1 or 4 days. The differentially expressed genes were identified and analyzed for enriched networks and pathways using Ingenuity Pathway Analysis (IPA). We have identified 140 and 230 genes that significantly changed more than 1.5 fold after PM exposure for 1 or 4 days, respectively. IPA analysis revealed that different exposure durations triggered distinct pathways. Genes involved in NRF2-mediated response to oxidative stress were up-regulated after 1 day exposure. In contrast, cells exposed for 4 days exhibited significantly changes in genes related to cholesterol and lipid synthesis pathways.

2012-08-01 | GSE38172 | GEO

whole genome sequencing of Staphylococcus aureus from Saudi Arabia

Project description:MRSA genomic epidemiology in Saudi Arabia

| PRJEB59751 | ENA

Gene expression profiling and pathway analysis of human bronchial epithelial cells exposed to airborne particulate matter collected from Saudi Arabia

2012-07-31 | E-GEOD-38172 | biostudies-arrayexpress

Safety and Effectiveness Study of Remsima in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients

Project description:The purpose of this observational study is to assess the safety and effectiveness of biosimilar Infliximab in patients with inflammatory bowel disease (IBD) in Saudi Arabia where no visits or intervention(s) additional to the daily practice will be performed.

| 2267353 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data